ArticleFrontiers in immunology2025

First-in-human evaluation of a no-alpha interleukin-2 mutein: safety and preliminary pharmacodynamic and clinical effect.

Iraida Caballero Aguirrechu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.